Oncolytics Biotech Inc to Discuss Recent Highlights and Expanded Catalysts and Milestones Call Transcript
Good morning, ladies and gentlemen. My name is Tom. I'll be your conference operator today. At this time, I'd like to welcome everyone to the Oncolytics Biotech Corporate Update Call. (Operator Instructions) I would now like to turn the call over to your host, Mr. Michael Moore, Vice President, Investor Relations and Corporate Communications. Mr. Moore, please go ahead.
Thank you, Tom. Good morning, ladies and gentlemen, and thank you for joining us on our call today to discuss our corporate update, including our updated catalysts and milestones.
With me on the call this morning from Oncolytics are Dr. Matt Coffey, President and Chief Executive Officer; Kirk Look, Chief Financial Officer; and Andrew de Guttadauro, Global Head of Business Development. On today's call, Dr. Coffey will review our clinical and operational progress and provide an update on our clinical development plan and strategy, including our growing critical mass in catalysts and milestones. Andrew will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
